 Drug Evaluation
"Drug Evaluation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals.
| Descriptor ID |
D004341
|
| MeSH Number(s) |
E05.337.425
|
| Concept/Terms |
Drug Evaluation- Drug Evaluation
- Drug Evaluations
- Evaluation, Drug
- Evaluations, Drug
- Evaluation Studies, Drug
- Drug Evaluation Studies
- Drug Evaluation Study
- Evaluation Study, Drug
- Studies, Drug Evaluation
- Study, Drug Evaluation
|
Below are MeSH descriptors whose meaning is more general than "Drug Evaluation".
Below are MeSH descriptors whose meaning is more specific than "Drug Evaluation".
This graph shows the total number of publications written about "Drug Evaluation" by people in this website by year, and whether "Drug Evaluation" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1981 | 0 | 1 | 1 | | 1982 | 0 | 3 | 3 | | 1983 | 0 | 2 | 2 | | 1984 | 0 | 5 | 5 | | 1985 | 0 | 3 | 3 | | 1986 | 0 | 5 | 5 | | 1987 | 0 | 4 | 4 | | 1988 | 0 | 3 | 3 | | 1989 | 0 | 4 | 4 | | 1990 | 0 | 5 | 5 | | 1991 | 0 | 2 | 2 | | 1992 | 0 | 1 | 1 | | 1998 | 1 | 0 | 1 | | 1999 | 1 | 0 | 1 | | 2001 | 0 | 1 | 1 | | 2002 | 0 | 1 | 1 | | 2004 | 0 | 1 | 1 | | 2005 | 0 | 2 | 2 | | 2007 | 0 | 1 | 1 | | 2009 | 0 | 1 | 1 | | 2010 | 0 | 1 | 1 | | 2020 | 0 | 1 | 1 | | 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Evaluation" by people in Profiles.
-
Mahmud F, Roy R, Mohamed MF, Aboonabi A, Moric M, Ghoreishi K, Bayat M, Kuzel TM, Reiser J, Shafikhani SH. Therapeutic evaluation of immunomodulators in reducing surgical wound infection. FASEB J. 2022 01; 36(1):e22090.
-
Feng L, Pomel S, Latre de Late P, Taravaud A, Loiseau PM, Maes L, Cho-Ngwa F, Bulman CA, Fischer C, Sakanari JA, Ziniel PD, Williams DL, Davioud-Charvet E. Repurposing Auranofin and Evaluation of a New Gold(I) Compound for the Search of Treatment of Human and Cattle Parasitic Diseases: From Protozoa to Helminth Infections. Molecules. 2020 Nov 01; 25(21).
-
Espinosa I, Fogelfeld L. Tagatose: from a sweetener to a new diabetic medication? Expert Opin Investig Drugs. 2010 Feb; 19(2):285-94.
-
Berger M, Pinciaro PJ, Althaus A, Ballow M, Chouksey A, Moy J, Ochs H, Stein M. Efficacy, pharmacokinetics, safety, and tolerability of Flebogamma 10% DIF, a high-purity human intravenous immunoglobulin, in primary immunodeficiency. J Clin Immunol. 2010 Mar; 30(2):321-9.
-
Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Dunlop BW, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen R, Yan B, Ahmed S, Schmidt M, Ninan PT. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases. Biol Psychiatry. 2007 Dec 15; 62(12):1371-9.
-
Truong D, Duane DD, Jankovic J, Singer C, Seeberger LC, Comella CL, Lew MF, Rodnitzky RL, Danisi FO, Sutton JP, Charles PD, Hauser RA, Sheean GL. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study. Mov Disord. 2005 Jul; 20(7):783-91.
-
Bala L, Boggio L, Green D. Effectiveness of D-arginine vasopressin in von Willebrand's disease. Curr Hematol Rep. 2005 Jan; 4(1):1-2.
-
Brotman DJ, Jaffer AK, Hurbanek JG, Morra N. Warfarin prophylaxis and venous thromboembolism in the first 5 days following hip and knee arthroplasty. Thromb Haemost. 2004 Nov; 92(5):1012-7.
-
Somberg JC. Biologic problems. Am J Ther. 2002 Nov-Dec; 9(6):471.
-
Somberg JC. Class effects of pharmaceuticals and therapeutic interchangeability. Am J Ther. 2001 Jul-Aug; 8(4):221-2.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|